These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4550228)

  • 1. Restriction by polycations of infection with myxoma virus in rabbits.
    Wegner DL; Hinze HC
    J Infect Dis; 1972 Feb; 125(2):141-5. PubMed ID: 4550228
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1981; 70(2):157-64. PubMed ID: 7332492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the ergastoplasm in the morphogenetic cycle of a virus from a myxoamtosis strain].
    Thomas JA; Henry M; Hollande E; Lambré C
    C R Acad Hebd Seances Acad Sci D; 1972 Dec; 275(25):3047-52. PubMed ID: 4631977
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A; Nation N; Graham K; McFadden G
    Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxomatosis vaccine.
    Lawton MP
    Vet Rec; 1992 May; 130(18):407-8. PubMed ID: 1609472
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection for resistance to myxomatosis in domestic rabbits (Oryctolagus cuniculus).
    Sobey WR
    J Hyg (Lond); 1969 Dec; 67(4):743-54. PubMed ID: 5261215
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
    Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
    Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphogenesis of the rabbit myxomatosis virus].
    Tektoff J; Gazzolo L; Leftheriotis E
    Pathol Biol (Paris); 1971 Dec; 19(23):1045-54. PubMed ID: 4945755
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral skin diseases of the rabbit.
    Meredith AL
    Vet Clin North Am Exot Anim Pract; 2013 Sep; 16(3):705-14. PubMed ID: 24018033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of an attenuated strain of infectious myxoma virus obtained by passage in cell cultures (MacKercher and Saito, 1964)].
    Jacotot H; Virat B; Reculard P; Vallée A; Le Bouquin MJ; Boutry JM; Gobert D
    Ann Inst Pasteur (Paris); 1967 Aug; 113(2):221-37. PubMed ID: 6055855
    [No Abstract]   [Full Text] [Related]  

  • 13. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination strategies against myxomavirus infections: are we really doing the best?
    Marlier D
    Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of vaccine against myxomatosis using live MXT by means of external ear puncture with a special needle].
    Cupera Z; Krupka V; Jiran E
    Vet Med (Praha); 1982; 27(10):617-26. PubMed ID: 6815860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival.
    Guitton JS; Devillard S; Guénézan M; Fouchet D; Pontier D; Marchandeau S
    Prev Vet Med; 2008 Apr; 84(1-2):1-10. PubMed ID: 18045714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vaccine against myxomatosis and RHD: a step forward for rabbit health.
    Meredith A
    Vet Rec; 2012 Mar; 170(12):307-8. PubMed ID: 22447788
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous lesions in pet rabbits following subcutaneous administration of a novel bivalent vaccine against myxomatosis and rabbit haemorrhagic disease.
    Selleri P; Di Girolamo N; Vögtlin A; Fileccia I; Hoop R; Bongiovanni L
    Vet Dermatol; 2014 Dec; 25(6):563-6, e100. PubMed ID: 25227274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
    Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxomatosis in wild rabbit: design of control programs in Mediterranean ecosystems.
    García-Bocanegra I; Astorga RJ; Napp S; Casal J; Huerta B; Borge C; Arenas A
    Prev Vet Med; 2010 Jan; 93(1):42-50. PubMed ID: 19818517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.